Preclinical applications and studies

  1. Overcoming Clinical Challenges In Metabolic And Cardiovascular Disease With Metabolomics
    4/10/2013

    Metabolic diseases (e.g. obesity, type 2 diabetes, and hypertension) are a rapidly expanding health care concern. Although there is a high demand for novel therapies, the challenges are substantial as existing drugs typically fail due to lack of efficacy or safety, and clinical studies often extremely large and protracted. 

  2. Overcoming Clinical Challenges In Oncology With Metabolomics
    4/10/2013

    Cancer continues to be a formidable disease with an overall success rate of bringing new drugs to market of only 5-8%.

  3. Streamline And Accelerate A Drug Development Plan Using The 505(b)(2) Pathway
    2/19/2013

    An international pharmaceutical company approached Camargo Pharmaceutical Services to help navigate the Food and Drug Administration (FDA) 505(b)(2) approval pathway for a promising drug under development designated for patients with cardiovascular disease. Product X is a prodrug that is converted in one metabolism-dependent step to produce the active metabolite of an approved drug.

  4. Accelerating Preclinical Studies With Project Tracking And Optimization Software
    2/13/2013

    A large pharmaceutical company with globally distributed preclinical R&D operations including externalized services implemented an advanced assay/ study tracking and optimization system in conjunction with its enterprise electronic lab notebook.

  5. CRO PharmaLegacy Achieves 10x Improvement With IDBS
    2/1/2012
    PharmaLegacy Laboratories is a leading Shanghai-based CRO providing specialty preclinical services for a worldwide clientele.